Prudential plc

The stock is in a corrective regime, trading below both its 50-day and 200-day moving averages. It sits well off the 52-week high and closer to the lower half of its annual range, which points to a rebuilding phase rather than a confirmed uptrend.

Street sentiment stays constructive, with a Buy consensus and a $38.66 average target versus a much lower share price. Recent changes have mostly been reiterations and target adjustments, led by Morgan Stanley, Barclays, UBS, and Citi, which suggests steady but not urgent conviction.

The next print is set for 2026-08-26, and the backdrop is mixed. Earnings growth has been solid at 30.8% year over year, but next-year EPS estimates are lower at 2.17 versus 3.07 TTM, so shareholders should watch margin durability and whether growth can reaccelerate.

No notable insider buying or selling in recent quarters. With no reported transactions, there is no discretionary signal to read into from management activity.

Profitability remains strong, with a 45.48% operating margin, 27.57% net margin, and 20.58% ROE. Revenue grew 18.8% year over year, while free cash flow reached $2.38 billion, giving the business a solid cash-generation profile.

PUK’s appeal is its life and health insurance footprint across Asia and Africa, with asset management as a secondary lever. At 8.99x earnings, it screens below many financials and looks inexpensive relative to the $38.66 consensus target.